# ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood

Study · id `cardio:ct-nct06078943` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06078943](<https://clinicaltrials.gov/study/NCT06078943>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06078943

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 612 participants.

## Technical summary

Registry record NCT06078943. Randomized; no masking; primary purpose other. Start 2023-03-17 (actual); primary completion 2024-01-13 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 612 participants (planned count; ClinicalTrials.gov record NCT06078943, source copy `cardio:ctgov-nct06078943-2023-10-12`, retrieved 2026-10-26)
- Started: 2023-03-17 (actual) (ClinicalTrials.gov record NCT06078943, source copy `cardio:ctgov-nct06078943-2023-10-12`, retrieved 2026-10-26)
- Primary completion: 2024-01-13 (anticipated) (ClinicalTrials.gov record NCT06078943, source copy `cardio:ctgov-nct06078943-2023-10-12`, retrieved 2026-10-26)
- Completion: 2024-01-30 (anticipated) (ClinicalTrials.gov record NCT06078943, source copy `cardio:ctgov-nct06078943-2023-10-12`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06078943, source copy `cardio:ctgov-nct06078943-2023-10-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06078943-2023-10-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood
- Condition: Congenital Heart Disease
- Intervention (Device): method comparison
- Lead sponsor: Radiometer Medical ApS
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)

## Provenance

Content hash: c8c1d34ef5f791ce6537e11717a7005e8a5ae21abd64732787672fd846ae9cbd
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
